瑞斯康集團(01679.HK):可換股債券初步兑換價調整為每股0.8港元
格隆匯 6 月 24日丨瑞斯康集團(01679.HK)宣佈,於2020年6月24日,公司與債券持有人訂立修訂協議,據此,公司與債券持有人已有條件地同意將可換股債券下的兑換價由初步兑換價每股兑換股份2.50港元修訂為經調整兑換價每股兑換股份0.80港元。
於公告日期,概無因可換股債券獲行使而發行兑換股份。假設按經調整兑換價0.80港元悉數行使可換股債券,則可換股債券將兑換為1.875億股兑換股份,分別相當於公告日期公司已發行股本約19.00%及經發行兑換股份擴大的公司已發行股本約15.97%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.